Results 131 to 140 of about 51,741 (305)

Antibody responses after SARS-CoV-2 infection and vaccination in the UK general population [PDF]

, 2023
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic since its first identification in December 2019.
Wei, Jia
core   +2 more sources

Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers

New England Journal of Medicine, 2021
Breakthrough SARS-CoV-2 Infections in Health Care Workers In a German study, 4 health care workers out of 1137 (0.35%) who had received one of the mRNA SARS-CoV-2 vaccines had mildly symptomatic Co...
Lange, Bettina, Gerigk, Marlis, Tenenbaum, Tobias   +2 more
openaire   +2 more sources

Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection

Frontiers in Immunology, 2022
Three COVID-19 vaccines have received FDA-authorization and are in use in the United States, but there is limited head-to-head data on the durability of the immune response elicited by these vaccines.
Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Jaimin Patel, Lyndsey M. Muehling, Glenda Canderan, Deborah D. Murphy, Savannah G. Brovero, Samuel M. Ailsworth, Will H. Eschenbacher, Emily C. McGowan, Barbara J. Mann, Michael R. Nelson, Alexandra Kadl, Alexandra Kadl, Judith A. Woodfolk, Thomas A.E. Platts-Mills, Jeffrey M. Wilson   +17 more
doaj   +1 more source

Risk of myocarditis following sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex [PDF]

, 2022
Myocarditis is more common after severe acute respiratory syndrome coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and after sequential vaccine doses are less certain.
Channon, Keith M, Coupland, Carol AC, Dixon, Sharon, Handunnetthi, Lahiru, Harnden, Anthony, Hippisley-Cox, Julia, Khunti, Kamlesh, Mei, Xue W, Mills, Nicholas L, Patone, Martina, Shankar-Hari, Manu, Sheikh, Aziz, Watkinson, Peter, Zaccardi, Francesco   +13 more
core   +1 more source

Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection [PDF]

, 2021
José Javier Morales‐Núñez, José Francisco Muñóz-Valle, Carlos Meza-López, Lin‐Fa Wang, Andrea Carolina Machado-Sulbarán, Paola Carolina Torres-Hernández, Martín Bedolla‐Barajas, Brenda De la O-Gómez, Paulina Balcázar-Félix, Jorge Hernández‐Bello   +9 more
openalex   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.

Journal of the American Medical Association (JAMA), 2021
Methods | Healthcareworkersatatertiarycarecenter(Ziekenhuis Oost-Limburg, Belgium) who were scheduled for vaccination with 2 doses of either mRNA-1273 or BNT162b2 were invited to participate in this prospective cohort.
D. Steensels, Noella Pierlet, J. Penders, D. Mesotten, L. Heylen   +4 more
semanticscholar   +1 more source

Humoral epitope dominance and immune imprinting by SARS‐CoV‐1 and SARS‐CoV‐2 vaccines

Immunology &Cell Biology, EarlyView.
We investigated Modified Vaccinia Ankara (MVA) vaccine candidates expressing the SARS‐CoV‐1 or SARS‐CoV‐2 Spike, as a primary or booster immunization, for their ability to induce antibodies targeting different epitopes on the SARS‐CoV‐2 RBD and broad cross‐reactive or cross‐neutralizing responses in C57BL/6 and antibody humanized (Ig‐humanized) mice ...
Deborah L Burnett, Ania Moxon, Anupriya Aggarwal, Katherine JL Jackson, Catherine Cotter, Anouschka Akerman, Amanda Russell, Rachel Kalman, David Langley, Jake Y Henry, Daniel Christ, Rowena A Bull, Robert Brink, Anthony D Kelleher, Hans‐Martin Jäck, Stuart Turville, Bernard Moss, Christopher C Goodnow   +17 more
wiley   +1 more source

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

medRxiv, 2021
The emergence of the Omicron variant (1) of SARS-CoV-2 in November 2021 in South Africa has raised concerns that, based on the large number of mutations in the spike protein and elsewhere on the virus (https://covdb.stanford.edu/page/mutation-viewer ...
S. Cele, Laurelle Jackson, K. Khan, D. Khoury, T. Moyo-Gwete, H. Tegally, C. Scheepers, D. Amoako, F. Karim, M. Bernstein, G. Lustig, D. Archary, Muneerah Smith, Y. Ganga, Z. Jule, K. Reedoy, D. Cromer, J. E. San, Shi-Hsia Hwa, J. Giandhari, J. Blackburn, B. Gosnell, S. Karim, W. Hanekom, A. von Gottberg, J. Bhiman, R. Lessells, M. S. Moosa, M. Davenport, Túlio de Oliveira, P. Moore, A. Sigal   +31 more
semanticscholar   +1 more source

Uveitis and other ocular complications following covid-19 vaccination [PDF]

, 2021
Coronavirus disease 2019 (COVID-19) vaccines can cause transient local and systemic post-vaccination reactions. The aim of this study was to report uveitis and other ocular complications following COVID-19 vaccination.
Adani C., Belloni L., Bolletta E., Bonacini M., Cimino L., Croci S., De Simone L., Fontana L., Gozzi F., Iannetta D., Mastrofilippo V., Salvarani C., Zerbini A.   +12 more
core   +1 more source